Results 81 to 90 of about 5,023,895 (307)

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

Lysis-buffer-treated versus intact plaques.

, 2019
H&E staining of s- and v-plaques on shows elimination of plaque surface cells (arrows) after lysis-buffer treatment.
Zhanna K. Nazarkina (6883388), Ivan S. Murashov (6883400), Evgeny A. Pokushalov (3234756), Olga A. Novikova (6883385), Petr P. Laktionov (6883394), Andrey A. Karpenko (6883406), Boris P. Chelobanov (6883397), Pavel P. Laktionov (2565487), Anna V. Cherepanova (6883391), Roman V. Deev (6883403)   +9 more
core   +1 more source

A Rare Case of Tumor Lysis Syndrome [PDF]

, 2015
INTRODUCTION Tumor lysis syndrome (TLS) is a metabolic disturbance caused by the destruction of rapidly dividing cancer cells following administration of cytotoxic chemotherapy.
Mainardi, MS4, Anne, Jianqing Lin, Okamoto, MD, Daniel, Daniel Okamoto, Anne Mainardi, Lin, MD, Jianqing   +5 more
core   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

the first experience of combined positioning of electrodes in electrochemical destruction of intraocular tumor in experi- ment

Oftalʹmologiâ, 2014
In experiment on fresh enucleated eyes with large tumors it was shown that a new method of electrochemical lysis with original combined positioning of electrodes for intraocular tumors treatment provides a minimal traumatic impact and total destruction ...
Yu. А. Belyy, A. V. Tereshchenko, А. В. Шацких   +2 more
doaj   +3 more sources

Síndrome de lise tumoral: uma revisão abrangente da literatura Acute tumor lysis syndrome: a comprehensive review

Revista Brasileira de Terapia Intensiva, 2008
A síndrome de lise tumoral é caracterizada pela destruição maciça de células malignas e conseqüente liberação do seu conteúdo no espaço extracelular. Embora possa ocorrer de modo espontâneo, a síndrome de lise tumoral aparece em geral, logo após o início
Michael Darmon, Sandra Malak, Isabelle Guichard, Benoit Schlemmer   +3 more
doaj   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

STAT: Tumor Lysis Syndrome

Clinical Journal of Oncology Nursing, 2020
Tumor lysis syndrome is when large numbers of rapidly dividing cells are killed and release their contents into the bloodstream. .
openaire   +3 more sources

Hyperuricemic Renal Failure in Nonhematologic Solid Tumors: A Case Report and Review of the Literature

Case Reports in Medicine, 2012
Tumor lysis syndrome (TLS) is an oncologic emergency that is caused by massive tumor cell lysis. It is commonly associated with hematological cancers like leukemia and lymphoma and uncommonly with solid nonhematologic tumors as well. However, spontaneous
Neeraj Saini, Kyeong Pyo Lee, Smita Jha, Sanket Patel, Neelima Bonthu, Ankit Kansagra, Ashmeet Bhatia, Sandra E. Martinez, Jaymin Patel, Sarah Altamimi, Sara Ghotb   +10 more
doaj   +1 more source

Transient myeloproliferative disorder in a newborn with down syndrome treated with rasburicase for the risk of development of tumor lysis syndrome: A case report

Journal of Medical Case Reports, 2011
Introduction Transient myeloproliferative disorder is a hematologic abnormality characterized by an uncontrolled proliferation of myeloblasts in peripheral blood and bone marrow that primarily affects newborns and babies with Down syndrome.
Hatzistilianou Maria, Hatzipantelis Emmanuel, Papageorgiou Theodotis, Pana Zoe, Tragiannidis Athanasios, Athanassiadou Fani   +5 more
doaj   +1 more source